Overview
Updated 14 Jul 2026
Vinod K. Rustgi, MD, is Distinguished Professor of Medicine at Rutgers Robert Wood Johnson Medical School, Division of Gastroenterology and Hepatology, Department of Medicine, New Brunswick, NJ. The public record shows 296 publications with 19,794 citations (h-index 44), centered on Liver Disease Diagnosis and Treatment, Hepatitis C virus research, Liver Disease and Transplantation. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 19 companies.
- Most recent indexed publication: 2024 · Alimentary pharmacology & therapeutics
- Top research focus: Liver Disease Diagnosis and Treatment
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 19 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 9 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 129.
Clinical & industrytrials, payments and federal funding
Federally funded research awards.
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C Patients
Sponsor: Romark Laboratories L.C.
InvestigatorPhase 2CompletedNCT00637923 - HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B Infection
Sponsor: Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
InvestigatorPhase 2TerminatedNCT00228592
Industry payments
Updated 14 Jul 2026
19 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Madrigal PharmaceuticalsProgram year202585 payments$109,441openpaymentsdata.cms.gov ↗
- Gilead Sciences, Inc.Program year202523 payments$13,362openpaymentsdata.cms.gov ↗
- ABBVIE INC.Program year202510 payments
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Nonalcoholic Fatty Liver Disease in Lean/Nonobese and Obese Individuals: A Comprehensive Review on Prevalence, Pathogenesis, Clinical Outcomes, and Treatment.
Journal of clinical and translational hepatology
2023 - Cost-effectiveness and potential value of pharmaceutical treatment of nonalcoholic fatty liver disease.
Journal of medical economics
2022
Most-cited worksby citation count (OpenAlex)
Contact
No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →
Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthcare6.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rwjms.rutgers.edu ↗
- Board certified
Gastroenterology and Internal Medicine (fellowship training in gastroenterology/liver diseases at Stanford and NIH)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Editorial & leadership rolesjournal and society appointments
- Governing Board Member
American Association for the Study of Liver Diseases (AASLD)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rwjms.rutgers.edu ↗ - Formerly Medical Director of Liver Transplantation
Thomas E. Starzl Transplantation Institute, University of Pittsburgh
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rwjms.rutgers.edu ↗
Awards & honorshonors on the public record
- Fellow
American Association for the Study of Liver Diseases (AASLD)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rwjms.rutgers.edu ↗ - Fellow
Royal College of Physicians
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
Secondary affiliationsappointments beyond the home institution
- Professor of Epidemiology
Rutgers School of Public Health
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rwjms.rutgers.edu ↗ - Professor
Department of Pathology and Laboratory Medicine, Rutgers RWJMS
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rwjms.rutgers.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/vinod-rustgi-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/profile/Vinod-Rustgi-2
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - LinkedIn
linkedin.com/in/vinod-rustgi-69b882a
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
Mentions by otherswhere others cite or feature them
- X / Twitter
x.com/AGA_Gastro/status/1400145576625414148
- YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.